Literature DB >> 23266623

A novel mitochondrial mutation m.8989G>C associated with neuropathy, ataxia, retinitis pigmentosa - the NARP syndrome.

Morten Duno1, Flemming Wibrand, Kirsten Baggesen, Thomas Rosenberg, Niels Kjaer, Anja L Frederiksen.   

Abstract

The archetypal NARP syndrome is almost exclusively associated with the m.8993T>C/G mutation in the sixth subunit of the mitochondrial ATP synthase, whereas other mutations in the MT-ATP6 gene primarily associate with Leigh syndrome or Leber's hereditary optic neuropathy (LHON). We report a novel mitochondrial point mutation, m.8989G>C, in a patient presenting with neuropathy, ataxia and retinitis pigmentosa constituting the classical NARP phenotype. This mutation alters the amino acid right next to canonical NARP mutation. We suggest that classic NARP syndrome relates to a defined dysfunction of p.MT-ATP6.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266623     DOI: 10.1016/j.gene.2012.12.066

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

Review 1.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

Review 2.  MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.

Authors:  Rebecca D Ganetzky; Claudia Stendel; Elizabeth M McCormick; Zarazuela Zolkipli-Cunningham; Amy C Goldstein; Thomas Klopstock; Marni J Falk
Journal:  Hum Mutat       Date:  2019-03-04       Impact factor: 4.878

Review 3.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

4.  Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.

Authors:  Masaaki Komatsu; Heather E Wheeler; Suyoun Chung; Siew-Kee Low; Claudia Wing; Shannon M Delaney; Lidija K Gorsic; Atsushi Takahashi; Michiaki Kubo; Deanna L Kroetz; Wei Zhang; Yusuke Nakamura; M Eileen Dolan
Journal:  Clin Cancer Res       Date:  2015-05-26       Impact factor: 12.531

5.  A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism.

Authors:  Laura Kytövuori; Joonas Lipponen; Harri Rusanen; Tuomas Komulainen; Mika H Martikainen; Kari Majamaa
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

Review 6.  Recent advances of stem cell therapy for retinitis pigmentosa.

Authors:  Yuxi He; Yan Zhang; Xin Liu; Emma Ghazaryan; Ying Li; Jianan Xie; Guanfang Su
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

7.  Large-scale mitochondrial DNA deletion underlying familial multiple system atrophy of the cerebellar subtype.

Authors:  Abdulaziz Alsemari; Hindi Nasser Al-Hindi
Journal:  Clin Case Rep       Date:  2015-11-23

Review 8.  The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases.

Authors:  Sabrina Carrella; Filomena Massa; Alessia Indrieri
Journal:  Front Cell Dev Biol       Date:  2021-06-18

9.  NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA SYNDROME: A MULTIDISCIPLINARY DIAGNOSIS.

Authors:  Leire Juaristi; Cristina Irigoyen; Jorge Quiroga
Journal:  Retin Cases Brief Rep       Date:  2021-07-01

10.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.